Decalcifier solution

Hazard statements (CLP)

H315, H319

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

No additional information available

Hazard pictograms

GHS07 GHS05

Signal word

Warning

Contains

Formic acid 98%

Hazard statements

H315 - Causes skin irritation. H319 - Causes serious eye irritation.

Precautionary statements

P260 - Do not breathe dust/fume/gas/mist/vapours/spray. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308+P313 - IF exposed or concerned: Get medical advice/attention.

PBT Substances

not relevant – no registration required Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component not relevant – no registration required Formaldehyde solution (50-00-0) The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Component Substance(s) not included in the list established in Formaldehyde solution (50-00-0) accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Full text of H and EUH statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available